Novavax (NVAX) Goodwill (2016 - 2025)
Novavax (NVAX) has 16 years of Goodwill data on record, last reported at $113.1 million in Q3 2025.
- For Q3 2025, Goodwill fell 10.8% year-over-year to $113.1 million; the TTM value through Sep 2025 reached $113.1 million, down 10.8%, while the annual FY2024 figure was $107.5 million, 15.67% down from the prior year.
- Goodwill reached $113.1 million in Q3 2025 per NVAX's latest filing, roughly flat from $113.0 million in the prior quarter.
- Across five years, Goodwill topped out at $132.0 million in Q3 2021 and bottomed at $107.5 million in Q4 2024.
- Average Goodwill over 5 years is $122.7 million, with a median of $125.1 million recorded in 2022.
- The widest YoY moves for Goodwill: up 2.41% in 2024, down 15.67% in 2024.
- A 5-year view of Goodwill shows it stood at $131.5 million in 2021, then dropped by 3.92% to $126.3 million in 2022, then grew by 0.89% to $127.5 million in 2023, then decreased by 15.67% to $107.5 million in 2024, then rose by 5.21% to $113.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Goodwill were $113.1 million in Q3 2025, $113.0 million in Q2 2025, and $112.0 million in Q1 2025.